The company develops natural and minimally invasive treatments for tissue reconstruction and regeneration, with applications in different medical fields.
4Tissue has raised €1.5M across 1 funding round, most recently a round in Feb 2025. Based in Ghent, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-28 | Other | €1.5M |
| — |
| View deal → |
